ENST00000361789.2:c.47A>G

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4BP6_Very_StrongBA1

The ENST00000361789.2(MT-CYB):​c.47A>G​(p.His16Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 4/4 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H16Y) has been classified as Uncertain significance.

Frequency

Mitomap GenBank:
𝑓 0.020 ( AC: 1251 )

Consequence

MT-CYB
ENST00000361789.2 missense

Scores

Apogee2
Benign
0.025

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2
No linked disesase in Mitomap

Conservation

PhyloP100: 1.53

Publications

17 publications found
Variant links:
Genes affected
MT-CYB (HGNC:7427): (mitochondrially encoded cytochrome b) Predicted to enable metal ion binding activity. Predicted to be involved in several processes, including electron transport coupled proton transport; response to cobalamin; and response to glucagon. Located in mitochondrion. Implicated in ovarian carcinoma and urinary bladder cancer. [provided by Alliance of Genome Resources, Apr 2022]
MT-ND6 (HGNC:7462): (mitochondrially encoded NADH dehydrogenase 6) Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone and mitochondrial respiratory chain complex I assembly. Predicted to be located in mitochondrial inner membrane. Implicated in Leber hereditary optic neuropathy; Leigh disease; and spinal muscular atrophy with lower extremity predominante 2B. [provided by Alliance of Genome Resources, Apr 2022]
TRNE (HGNC:7479): (mitochondrially encoded tRNA glutamic acid)
TRNE Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: Mitochondrial Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Apogee2 supports a benign effect, 0.024961192 < 0.5 .
BP6
Variant M-14793-A-G is Benign according to our data. Variant chrM-14793-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 693766.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
High frequency in mitomap database: 0.020499999

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000361789.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MT-CYB
ENST00000361789.2
TSL:6
c.47A>Gp.His16Arg
missense
Exon 1 of 1ENSP00000354554.2P00156
MT-ND6
ENST00000361681.2
TSL:6
c.-120T>C
upstream_gene
N/AENSP00000354665.2P03923
MT-TE
ENST00000387459.1
TSL:6
n.-51T>C
upstream_gene
N/A

Frequencies

Mitomap GenBank
AF:
0.020
AC:
1251
Gnomad homoplasmic
AF:
0.031
AC:
1770
AN:
56383
Gnomad heteroplasmic
AF:
0.000035
AC:
2
AN:
56383
Alfa
AF:
0.0307
Hom.:
138

Mitomap

No disease associated.

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Leigh syndrome (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
Apogee2
Benign
0.025
Hmtvar
Benign
0.17
AlphaMissense
Benign
0.096
PhyloP100
1.5
Mutation Taster
=82/18
polymorphism

Publications

Other links and lift over

dbSNP: rs2853504; hg19: chrM-14794; API